Accessibility Menu
Shandong Weigao Group Medical Polymer logo

Shandong Weigao Group Medical Polymer(OTC) SHWGY

Current Price$1.60
Market Cap$1.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)-74%
5 Year-75%
1 Year-49%
1 Month-5%
Shandong Weigao Group Medical Polymer last closing stock price
MetricPriceDate
Last closeUSD 1.602026-07-22
Shandong Weigao Group Medical Polymer stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.31%USD 1.602026-07-09
1 month-4.76%USD 1.682026-06-22
3 month+0.8%USD 1.592026-04-23
Year to date-38.84%USD 2.622025-12-31
1 year-48.79%USD 3.122025-07-10
3 year-66.91%USD 4.842023-07-21
5 year-75.16%USD 6.442021-07-23
Since inception-73.59%USD 6.062011-05-09

Shandong Weigao Group Medical Polymer Financials at a Glance

Market Cap

$1.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CN¥26.35B

Net Income (TTM)

CN¥3.67B

EPS (TTM)

$0.20

P/E Ratio

8.12

Dividend

$0.09

Beta (Volatility)

0.01 (Low)

Price

$1.60

Volume

197

Open

$1.60

Previous Close

$1.60

Daily Range

$1.60 - $1.60

52-Week Range

$1.49 - $3.51

Estimated Earnings Date

Mar 24, 2026

SHWGY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Shandong Weigao Group Medical Polymer

Shandong Weigao Group Medical Polymer Company Limited is a leading manufacturer of disposable medical products, established in 2000 and based in Weihai, China. The company specializes in the research, development, and distribution of a wide range of medical devices and supplies, catering to both domestic and international markets.

Products and Services
  • Disposable medical products including infusion sets and syringes
  • Orthopedic devices and interventional tools for various medical conditions
  • Pharma packaging products and blood management solutions
Growth Outlook
  • Revenue of CNY 6.62 billion reported in Q4 2025, indicating strong market demand
  • Net income of CNY 592 million in Q4 2025, showcasing profitability
  • Operating income margin of 10.56% in Q4 2025, reflecting operational efficiency
Financial Highlights
  • Trailing twelve months (TTM) revenue of CNY 26.5 billion, demonstrating consistent growth
  • Net profit margin of 12.04% TTM, indicating effective cost management
  • Current ratio of 3.78 TTM, suggesting strong liquidity position
Shandong Weigao Group Medical Polymer Company Limited operates in the healthcare sector, focusing on medical instruments and supplies. The company has established a robust product portfolio that includes essential medical devices, which are critical in various healthcare settings. The recent financial performance highlights a strong revenue stream and profitability, positioning the company favorably for future growth. The liquidity ratios indicate a solid financial foundation, allowing for potential investments in innovation and expansion. With a commitment to quality and a diverse range of products, Shandong Weigao is well-positioned to capitalize on the growing demand for medical supplies both in China and globally.
AI Generated • Jul 18, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

13,307

CEO

Rinan Cong, MBA

Website

www.weigaogroup.com

Headquarters

Weihai, SD 264210, CN

SHWGY Financials

Key Financial Metrics (TTM)

Gross Margin

47.26%

Operating Margin

12.69%

Net Income Margin

12.04%

Return on Equity

6.69%

Return on Capital

6.26%

Return on Assets

4.47%

Earnings Yield

12.32%

Dividend Yield

5.59%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.12B

Volume

197

Avg. Volume

563.871

Financials (TTM)

Gross Profit

CN¥12.71B

Operating Income

CN¥4.00B

EBITDA

CN¥6.02B

Operating Cash Flow

CN¥5.39B

Capital Expenditure

-CN¥2.32B

Free Cash Flow

CN¥3.07B

Cash & ST Invst.

CN¥9.87B

Total Debt

CN¥5.10B

Shandong Weigao Group Medical Polymer Performance Analysis

Shandong Weigao Group Medical Polymer annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CNY 2,041,588,504-0.3%
20232023-12-31CNY 1,867,240,593-8.5%
20242024-12-31CNY 1,818,452,514-2.6%
20252025-12-31CNY 1,862,556,4082.4%
Shandong Weigao Group Medical Polymer sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-304.8%
Q42024-12-31-2.8%
Q22025-06-303.0%
Q42025-12-31-0.4%
Shandong Weigao Group Medical Polymer annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CNY 0.3616.1%
20232023-12-31CNY 0.25-31.0%
20242024-12-31CNY 0.251.0%
20252025-12-31CNY 0.20-21.8%
Shandong Weigao Group Medical Polymer sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-3035.1%
Q42024-12-31-16.7%
Q22025-06-3010.0%
Q42025-12-31-40.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

CN¥6.62B

+4.6%

Gross Profit

CN¥2.87B

-6.3%

Gross Margin

43.40%

N/A

Market Cap

$1.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$135.01K

N/A

Employees

13,307

N/A

Net Income

CN¥592.74M

-26.3%

EBITDA

CN¥1.19B

-14.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

CN¥9.87B

+34.6%

Total Debt

CN¥5.10B

+22.4%

Accounts Receivable

CN¥8.29B

+13.1%

Inventory

CN¥2.52B

+0.9%

Long Term Debt

CN¥4.61B

+188.7%

Short Term Debt

CN¥498.43M

-80.6%

Return on Assets

4.47%

N/A

Return on Invested Capital

5.55%

N/A

Free Cash Flow

CN¥0.00

-100.0%

Operating Cash Flow

CN¥1.72B

+2.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TCHBFTecan Group AG
$225.65+0.00%
ANSLYAnsell Limited
$84.09+0.00%
ANSLFAnsell Limited
$21.64+0.00%
MAHLYMediPal Holdings Corporation
$17.63-2.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
FFord Motor Company
$14.37+0.02%

Questions About SHWGY

What is the current price of Shandong Weigao Group Medical Polymer?

Shandong Weigao Group Medical Polymer is trading at $1.60 per share.

What is the 52-week range for Shandong Weigao Group Medical Polymer?

Over the past 52 weeks, Shandong Weigao Group Medical Polymer has traded between $1.49 and $3.51.

How much debt does Shandong Weigao Group Medical Polymer have?

As of the most recent reporting period, Shandong Weigao Group Medical Polymer reported total debt of CN¥846.12M.

How much cash does Shandong Weigao Group Medical Polymer have on hand?

Shandong Weigao Group Medical Polymer reported CN¥1.29B in cash and cash equivalents in its most recent financial results.

What is Shandong Weigao Group Medical Polymer’s dividend yield?

Shandong Weigao Group Medical Polymer currently has a dividend yield of 5.59%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services